TransCode Therapeutics Inc (NASDAQ:RNAZ) currently has a daily average trading volume of 1.24M but it saw 6172287 shares traded in last market. With a market cap of 6.04M USD, the company’s current market price of $0.35 came rising about 20.69 while comparing to the previous closing price of $0.29. In past 52 weeks, the stock remained buoying in the range of price level as high as $128.00 and as low as $0.22. In the recent trading on the day, stock has struck highest price mark of $0.2759 while lowest mark touched by it was $0.4.
Taking a look at 20-day trading activity of TransCode Therapeutics Inc (RNAZ) gives us an average price of $0.2703, while its current price level is -99.73% below from 52-week high level whereas it is 62.04% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $0.3805 while that of 200 days or SMA-200 reads an average of $1.6267. A closer look into the stock’s movement over the week reveals that its volatility is standing at 17.99% during that period while stretching the period over a month that decreases to 12.17%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 59.47 which implies that the stock is in neutral territory.
Over the week, RNAZ’s stock price is moving 34.72% up while it is 29.68% when we observe its performance for the past one month. Year-to-date it is -94.69% down and over the past year, the stock is showing a downside performance of -98.51%.
Currently, TransCode Therapeutics Inc’s total number of outstanding shares is 17.27M. Company’s return on investment (ROI) stands at -1354.12% and return on equity (ROE) at -1048.70%. Stock’s beta reads 0.44. Stock has a price to book (P/B) ratio of 1.92. Its return on asset (ROA) is -334.48% on average.
